Core Viewpoint - Sunshine Biopharma Inc. has approved a strategic investment of $5 million in Bitcoin as a reserve asset, aiming to strengthen its financial foundation while advancing its drug pipeline [1] Financial Strategy - The investment in Bitcoin is part of a broader strategy to enhance the company's financial stability [1] - The company is focusing on developing generic prescription drugs and proprietary mRNA-based cancer therapies and antiviral drug candidates [1]

As filed with the Securities and Exchange Commission on February 9, 2024 Registration No. 333-276817 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A (Amendment No. 1) REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Sunshine Biopharma, Inc. (Exact name of registrant as specified in its charter) | Colorado | 8731 | 20-5566275 | | --- | --- | --- | | (State or other jurisdiction of | (Primary Standard Industrial | (I.R.S. Employer | | incorporation or organization) | ...

Table of Contents As filed with the Securities and Exchange Commission on February 1, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Sunshine Biopharma, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Colorado 8731 20-5566275 (I.R.S. Employer Identification Numbe ...